MedPath

Diet in the Management of Acromegaly

Not Applicable
Recruiting
Conditions
Acromegaly
Registration Number
NCT05401084
Lead Sponsor
Cedars-Sinai Medical Center
Brief Summary

Impact of low carbohydrate and low gluten diet on acromegaly progression, symptoms, complications, and treatment outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
9
Inclusion Criteria
  • Diagnosis of acromegaly.
Exclusion Criteria
  • Diet restrictions.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in acromegaly related symptoms.8 weeks

Change in acromegaly related symptoms will be assessed from baseline (pre-intervention) to end of follow up using Acromegaly Quality of Life Questionnaire (AcroQoL).

Change in growth hormone level (GH).8 weeks

Change in GH level will be assessed from baseline (pre-intervention) to end of follow up.

Change in insulin-like growth factor 1 (IGF-1).8 weeks

Change in IGF-1 will be assessed from baseline (pre-intervention) to end of follow up.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cedars-Sinai Medical Center

🇺🇸

Los Angeles, California, United States

Cedars-Sinai Medical Center
🇺🇸Los Angeles, California, United States
Vivian Hwe
Contact
424-315-4489

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.